A gene expression atlas of embryonic neurogenesis in Drosophila reveals complex spatiotemporal regulation of lncRNAs by McCorkindale, A.L. et al.
TECHNIQUES AND RESOURCES RESEARCH ARTICLE
A gene expression atlas of embryonic neurogenesis in Drosophila
reveals complex spatiotemporal regulation of lncRNAs
Alexandra L. McCorkindale1,2,*, Philipp Wahle1, Sascha Werner1, Irwin Jungreis3,4, Peter Menzel5, Chinmay
J. Shukla6,7, Rúben Lopes Pereira Abreu1, Rafael A. Irizarry7, Irmtraud M. Meyer5,8, Manolis Kellis4,5 and
Robert P. Zinzen1,*
ABSTRACT
Cell type specification during early nervous system development in
Drosophila melanogaster requires precise regulation of gene
expression in time and space. Resolving the programs driving
neurogenesis has been a major challenge owing to the complexity
and rapidity with which distinct cell populations arise. To resolve the cell
type-specific gene expression dynamics in early nervous system
development, we have sequenced the transcriptomes of purified
neurogenic cell types across consecutive time points covering crucial
events in neurogenesis. The resulting gene expression atlas comprises
a detailed resource of global transcriptome dynamics that permits
systematic analysis of how cells in the nervous system acquire distinct
fates. We resolve known gene expression dynamics and uncover novel
expression signatures for hundredsof genesamongdiverseneurogenic
cell types, most of which remain unstudied. We also identified a set of
conserved long noncoding RNAs (lncRNAs) that are regulated in a
tissue-specific manner and exhibit spatiotemporal expression during
neurogenesis with exquisite specificity. lncRNA expression is highly
dynamic and demarcates specific subpopulations within neurogenic
cell types. Our spatiotemporal transcriptome atlas provides a
comprehensive resource for investigating the function of coding genes
and noncoding RNAs during crucial stages of early neurogenesis.
KEY WORDS: Drosophila melanogaster, Embryogenesis, lncRNA,
Spatiotemporal transcriptome, Neurogenesis
INTRODUCTION
Development of complex tissues from naïve primordia requires the
precise spatiotemporal deployment of transcriptional programs as
cells subdivide, specify and differentiate. Owing to the availability
of tissue- and cell type-specific markers characteristic for
neurogenic cell types in the fruit fly embryo (Heckscher et al.,
2014), Drosophila neurogenesis is highly tractable and several
crucial regulators of neurogenesis have been identified over the past
several decades (Skeath and Thor, 2003; Beckervordersandforth
et al., 2008; Broadus et al., 1995; Landgraf et al., 1997; Rickert
et al., 2011;Wheeler et al., 2006; Doe, 2017; Heckscher et al., 2014;
Skeath et al., 1994;Weiss et al., 1998;Wheeler et al., 2009). Among
the earliest events in embryonic neurogenesis is the subdivision of
the lateral neurogenic ectoderm into columnar domains along the
dorsoventral axis (Von Ohlen and Doe, 2000; Cowden and Levine,
2003). This is followed by the formation of proneural clusters and
consecutive phases of delamination, whereby neuroblasts cease
contact with surrounding cells of the neuroectodermal columns and
ingress into the embryo (Campos-Ortega, 1995). Embryonic
neuroblasts – Drosophila neural stem cells – undergo a series of
self-renewing asymmetric divisions that produce ganglion mother
cells, which give rise to glia and neurons (Broadus et al., 1995;
Sousa-Nunes et al., 2010; Homem and Knoblich, 2012; Heckscher
et al., 2014). Importantly, each of the three neurogenic columns
gives rise to molecularly and functionally distinct sets of neuroblasts
(Doe, 1992), but the molecular mechanisms that link spatial origin
to the ensuing distinct fates remain poorly understood. To date, a
small set of marker genes specifically expressed in individual
columnar domains and in emerging cell types has been identified,
but it remains unclear how these cell populations differ with respect
to the global gene expression programs that shape their identities.
Although expression dynamics of protein-coding transcripts have
given important insights into the mechanisms that drive cellular
differentiation, it should be noted that an emerging class of
noncoding transcripts – the long noncoding RNAs (lncRNAs) –
may well emerge as pivotal regulators of neurogenesis. In
mammals, lncRNAs have been shown to be especially abundant
in differentiated neuronal cells (Briggs et al., 2015), are expressed
often with exquisite spatiotemporal specificity in the nervous
system (Sauvageau et al., 2013; Goff et al., 2015), and some
lncRNA species even exhibit neuronal subtype specificity
(Molyneaux et al., 2015; Liu et al., 2016). Though the functional
importance of some lncRNAs for development and cellular identity
has been demonstrated in Drosophila (Wen et al., 2016), including
in the nervous system (Li and Liu, 2015; Landskron et al., 2018),
very little is known about the cell type-specific expression and
function of lncRNAs over the course of early neurogenesis.
Large-scale efforts have characterized spatial gene expression in
RNA in situ hybridization screens (Tomancak et al., 2002; Inagaki
et al., 2005; Tomancak et al., 2007; Lécuyer et al., 2007; Wilk et al.,
2016), but such efforts are qualitative rather than quantitative and
largely exclude lncRNAs. In contrast, efforts to determine globalReceived 27 December 2018; Accepted 5 February 2019
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transcriptome dynamics in the developing Drosophila embryo
(Graveley et al., 2011; Brown et al., 2014; Young et al., 2012; Chen
et al., 2016) may detect the expression of lncRNAs, but lack cell
type resolution. As for most complex tissues, recapitulating early
neurogenesis in cell culture is unfortunately not an option, because
accurate specification and differentiation of cells depends on
embryonic context, intricate interactions among cells within the
neuroectoderm (Kunisch et al., 1994; Lai, 2004) and signaling
gradients involving surrounding tissues (Bier and De Robertis,
2015; Rogers et al., 2017).
To overcome these limitations and to dissect stage- and cell
type-specific transcriptomes in early neurogenesis, we adapted
MARIS (Hrvatin et al., 2014) for use in developing Drosophila
embryos. DIV-MARIS (Drosophila in vivo method for analyzing
RNA following intracellular sorting) allows purification of
chemically cross-linked cell types from staged developing
embryos based on marker gene expression, followed by RNA
extraction and next-generation sequencing. Here, we employ
DIV-MARIS to determine the transcriptome dynamics in distinct
neurogenic cell populations. We assess the gene expression
programs of two principal neurogenic domains (the ventral
and the intermediate columns) and of three differentiating cell
types (neuroblasts, neurons and glia) at consecutive time points
from primordial specification and subdivision to terminal
differentiation.
DIV-MARIS reveals an extensive network of dynamic
spatiotemporal gene expression during embryonic nervous system
development. Our method reliably identifies known cell type-
specific markers, but also reveals novel expression features.
Furthermore, we uncover many genes – most of which have
conserved homologs in human – that are expressed in distinct cell
types throughout early neurogenesis and for which the functions
remain to be elucidated. Hence, DIV-MARIS provides an accurate
expression map of spatiotemporal transcriptional programs driving
early nervous system development. Moreover, our analyses
identified many lncRNAs expressed in cell type-specific patterns
and for which no functional roles are yet known. Applying stringent
criteria for selection, we characterize 13 neural cell type-enriched
lncRNAs with varied temporal expression, abundance and
subcellular localization. In situ visualization of lncRNA
expression exposes an additional layer of specificity as neuroglial
lncRNAs tend to be expressed highly, but only in extremely distinct
subpopulations.
This study delivers a genome-wide, yet cell type-specific, view of
gene expression during Drosophila neurogenesis from neurogenic
columns to differentiated neurons and glia, provides insights into
the expression properties of the coding and noncoding
transcriptomes and will serve as a valuable tool for understanding
how regulated coding and noncoding gene expression drives cell
fate determination in early neurogenesis.
RESULTS
Isolation of neuroglial cell types with spatiotemporal
resolution
Early Drosophila neurogenesis starts with the specification of the
lateral neurogenic ectoderm at the onset of zygotic transcription.
The neurogenic ectoderm is quickly subdivided into distinct
neurogenic columns (Von Ohlen and Doe, 2000; Cowden and
Levine, 2003), from which neuroblasts delaminate and undergo
asymmetric division giving rise to ganglion mother cells (GMCs),
followed by differentiation of GMCs into neurons and glia
(Fig. 1A). To dissect the genome-wide transcriptional programs
driving early neurogenesis, we purified specific cell populations
comprising the neuroglial lineages using fluorescence-activated
cell sorting (FACS) of chemically fixed cells. We isolated cells of
the intermediate column (IC) and the ventral column (VC) using
transgenic constructs by fusing IC- or VC-specific enhancers to
reporter genes (Fig. S1A). Neuroblasts/GMCs, neurons and
glia cells were purified using antibodies directed against the
endogenous markers prospero ( pros), embryonic lethal abnormal
vision (elav) and reversed polarity (repo), respectively (Fig. 1D,
Fig. S1B). Early neurogenesis is a rapidly unfolding process, with
naïve primordia developing into differentiated cell types in a
matter of hours (Fig. S2A). To assess the temporal dynamics of
early neurogenesis, we collected these cell populations at
developmental stages (bins) that encompass crucial events along
the neurogenic lineages from early specification to terminal
differentiation (Fig. 1B, Fig. S2A). Timed embryo collections
were manually staged to confirm which neurogenic events were
captured within the collection bins (Fig. S2B). The earliest
collection bin (4-6 h after egg laying, AEL) primarily contains
embryos immediately after specification and subdivision of the
neurogenic ectoderm and encompasses the first rounds of
neuroblast delamination. The second bin (6-8 h AEL) includes
all waves of neuroblast delamination, proliferation and
diversification, followed by early differentiation in the third bin
(8-10 h AEL). A later collection towards the end of embryogenesis
(18-22 h AEL) serves as a reference point for fully differentiated
neurons and glia.
To isolate cell type-specific RNA from specific neurogenic cell
types, we adapted the MARIS protocol (Hrvatin et al., 2014), but
had to introduce several modifications to temporally resolve cell
types from complex and quickly developing Drosophila embryos
in vivo. DIV-MARIS (outlined in Fig. 1C) is a flexible method for
the isolation of high-quality RNA from specific fixed cell types
within complex and rapidly developing embryos. Briefly, staged
embryos are collected, dissociated into single-cell suspensions, and
immediately cross-linked with formaldehyde. Neurogenic cell types
were stained using antibodies, either against transgenic reporters
(for the ventral and intermediate columns; Fig. S1A), or against
endogenous markers (for neuroblasts/GMCs, neurons and glia;
Fig. 1D, Fig. S2B). Positively marked and unmarked populations
were purified by FACS (Fig. 1C). We used microscopy (e.g.
Fig. S1C) and analytical cytometry (e.g. Fig. S3) to confirm that
the sorting strategy reliably isolated marked cells of interest;
samples generally had purities >95% and samples below 90%
purity were discarded. Furthermore, we evaluated the enrichment of
DIV-MARIS-sorted cell types by quantitative RT-PCR against
several marker genes associated with the cell types of interest (i.e.
pros and worniu in neuroblasts/GMCs, elav and Lim3 in neurons,
repo and gcm in glia) as independent measures of cell-type
enrichment (Fig. 1E). We confirmed specific enrichment of the
expected markers in sorted cells compared with whole embryos, as
well as their depletion in sorted marker-negative cells.
As DIV-MARIS robustly isolates neurogenic cell populations of
interest, we extracted RNA from sorted populations at four
developmental time points for whole-transcriptome sequencing.
Principal component analysis demonstrated that variance between
samples is primarily due to developmental time and cell type of
origin (Fig. S4). The resulting cell type-specific gene expression
atlas quantitatively assesses neurogenic transcription in five distinct
neurogenic cell populations (enriched and depleted) across four
developmental time points covering major neurogenic events
(Fig. 1A,B).
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Cell type-specific expression of protein-coding genes during
neurogenesis
In addition to purity, we evaluated sorting specificity by assessing
gene expression of the five cell type marker genes (ind, vnd, pros,
elav and repo) across the sorted populations in terms of normalized
counts (Table S1). In all cases, strong enrichment of marker gene
expression levels in the marker-enriched compared with the
depleted samples was observed, as expected (Fig. 2A, Fig. S5).
For example, the high and near-exclusive enrichment of repo
transcript in purified glia demonstrates sorting effectiveness of DIV-
MARIS when using a highly specific and exclusive marker
(Fig. 2A, Fig. S5E). Similarly, elav transcript levels were highly
enriched in purified neurons compared with glia (Fig. 2A,
Fig. S5D), whereas lower levels were detected in early
neuroblasts and columnar material, which is in line with
observations that the common neuronal marker elav is transiently
expressed pan-neurogenically at the onset of differentiation (Berger
et al., 2007). The columnar markers vnd and ind mark distinct
columnar neurogenic territories that each give rise to neuroblasts,
neurons and glia. Accordingly, although vnd and ind transcripts
were largely exclusive to their respective neurogenic columns, each
was detectable to some degree in neuroblasts, most likely because
Fig. 1. DIV-MARIS for the enrichment of
staged neurogenic cell types. (A) Biological
materials studied over the course of
neurogenesis: intermediate column (IC); ventral
column (VC); neuroblasts (NBs); neurons; glia.
(B) Time windows (collection bins) of sorted
materials. (C) Overview of the DIV-MARIS
protocol. (D) Merge (right) of antibody (left) and
RNA-FISH (middle) shows that the sorting
strategy faithfully marks cell types of interest
(NBs, Pros; neurons, Elav; glia, Repo); embryos
at 6-8 h. (E) Expression of marker genes
specific to the cell type of interest measured by
qPCR in marker-enriched (M+), and marker-
depleted (M−) populations, calculated relative to
whole embryo (WE, dashed red line); embryos
collected at 4-10 h AEL. Error bars represent
s.e.m. Embryos are ∼500 µm in length, shown
anterior leftwards and ventral downwards;
stage 10/11.
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early neuroblasts stem from one of the respective neurogenic
columns co-purified by FACS (Fig. 2A, Fig. S5A-C). Interestingly,
normalized counts for vnd were higher than those for ind, which
likely reflects the fact that the ventral column generates more
neuroblasts in the first waves of delamination compared with the
intermediate column (Doe, 1992).
To validate cell type-specific gene expression, we examined
genes with known neurogenic roles (Von Ohlen and Doe, 2000;
Skeath and Thor, 2003; Sousa-Nunes et al., 2010; Crews, 2010;
Sandler and Stathopoulos, 2016) and confirmed specificity of
mRNA expression in cell types previously associated with gene
function (Fig. 2B). exex, for example, is a homeodomain
transcription factor required in motor neurons that project to
ventral somatic muscles (Santiago et al., 2014) and we found it
exclusively in young neurons (Fig. 2B). Whereas markers of
neuroblast identity were not only enriched in neuroblasts, but also
depleted in the differentiated cell types neuroblasts give rise to
(neuronal and especially glial), neurogenic column marker
expression was often maintained in neuroblasts, highlighting that
neuroblasts retain columnar identity after delamination, as they
adopt column-specific fates (Doe, 1992).
To systematically uncover protein-coding genes that demarcate
columnar and cell-type identities in nervous system development,
we looked for genes expressed in a similar pattern to known
Fig. 2. Defining mRNA signatures of neuroglial cell types. (A) Normalized expression values for each marker gene used for FACS (ind, vnd, pros, elav
and repo) across sorted samples. Error bars represent s.e.m. (B) Heat map of expression profiles of Drosophila nervous system genes. Row mean-centered
expression values calculated by variance-stabilizing transformation (VST) of gene-level RNA-seq counts (scale=log2 ratio of row mean).
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neurogenic genes by Pearson correlation (r>0.9).We uncovered 753
additional genes (summarized in Table S2) and though many have
no known association with embryonic neurogenesis, in situ screens
annotating expression using controlled anatomical imaging
vocabulary (ImaGO; Hammonds et al., 2013; Tomancak et al.,
2002, 2007) indicate that this gene set is indeed specifically
expressed in components of the developing nervous system. For
example, the most enriched ImaGO terms for this gene set include
‘ventral nerve cord primordium’, ‘brain primordium’ and ‘ventral
nerve cord’ (Fig. S6A). GO analysis revealed the most enriched
molecular function for this gene set to be ‘DNA binding’, and the
most enriched biological processes were ‘chromosome organization’
and ‘nucleic acid metabolic process’ (Fig. S6B,C). Furthermore,
protein domains enriched among the proteins specifically expressed
in compartments of the developing nervous system included
histone folds, chromatin interaction domains and sequence-specific
DNA-interaction domains, such as zinc fingers and homeobox
domains (Fig. S6D).
We were surprised that one-quarter of the genes deployed
similarly to known neurogenic marker genes remain largely
unstudied (199 ‘computed genes’) and though many of these
candidates lack any described function, more than 62% can be
directly mapped to human homologs and some have even been
linked to nervous system function.
We focused on a subset (40) of these genes, which were predicted
to be expressed in neuroglial cell types with clear spatiotemporal
specificity (Fig. S7A). In concordance with DIV-MARIS
predictions, RNA in situ hybridization data (Hammonds et al.,
2013; Tomancak et al., 2002, 2007) confirmed that a selection of
these candidate genes mark specific subsets of cells in the
developing nervous system (Fig. S7B).
Thus, DIV-MARIS reliably captures and uncovers cell type-
specific gene expression dynamics during embryogenesis. As many
of the specifically expressed genes encode known and predicted
transcription factors and signaling pathway components (Table S2),
this cell type-specific expression map identifies new regulatory
nodes that likely play central roles in the specification and
differentiation of neuroglial cell types.
Specific expression and properties of long noncoding RNAs
along the neuroglial lineage
To explore lncRNA expression during early neurogenesis, we first
identified nervous system-specific lncRNAs by calculating
enrichment of expression in marker-positive versus marker-
depleted samples at each time point using DESeq2 (Love et al.,
2014; log2FC>1.0, Padj<0.05). We found 325 such lncRNA
candidates (Table S3) and evaluated them according to several
criteria, including spatiotemporal regulation through neurogenesis,
expression above an abundance threshold [transcript counts per
million reads (TPM)>300] in at least one cell type, absence of sense
overlap with a protein-coding gene, and transcript boundaries
consistent with lncRNA annotations. Applying these stringent
criteria, we selected 13 high-confidence lncRNA candidates that are
strongly and specifically expressed in a variety of cell types of the
Drosophila nervous system (Fig. 3, Fig. S8).
To assess spatiotemporal expression of these lncRNAs, we
calculated their relative abundance among all cell types and
collection bins. The lncRNAs were depleted in marker-negative
non-neurogenic cells and exhibited dynamic spatiotemporal
enrichment in specific marker-positive cell types (Fig. 3A).
Strikingly, although we found very few lncRNAs with distinct
expression in the earlier and more naïve intermediate and ventral
columns, specific lncRNA deployment could be readily observed in
more mature and differentiated cell types, such as neuroblasts,
neurons and/or glia, indicating that lncRNA expression is a
hallmark of differentiated cells more so than of primordia.
To confirm that these transcripts are bona fide lncRNAs, we
evaluated the coding potential of each by phylogenetic codon
substitution frequency (PhyloCSF) (Lin et al., 2011). Each lncRNA
locus exhibited a total PhyloCSF score below zero across all frames,
consistent with a complete lack of coding potential (Fig. 3B). Given
that some lncRNAs have been shown to exhibit variable subcellular
localization with localized functions (Chen, 2016), we assessed the
general subcellular expression of these transcripts by Fractionation-
Seq. Briefly, we generated a subcellular reference transcriptome of
the cytoplasmic and nuclear compartments of 6-8 h and 18-22 h
embryos and examined abundance of each of these lncRNA
transcripts between these fractions. Intriguingly, the 13 lncRNAs
exhibited distinct subcellular localization patterns with varying
degrees of nuclear/cytoplasmic restriction (Fig. 3C), ranging from
almost exclusively cytoplasmic (e.g. CR30009 and cherub) to
almost exclusively nuclear (e.g. CR45312) detection, including
instances in which location appeared to be temporally regulated
(e.g. CR44978).
To assess lncRNA abundance relative to other transcripts
(noncoding and protein-coding) in the neurogenic cell types, we
normalized read counts for each transcript in each sample (TPM,
Table S4). The maximum expression score for lncRNAs across cell
types (maxTPM) showed that although expression varies among
lncRNAs, they are generally not expressed at low levels; rather,
lncRNA expression was well within the range of what may be
expected for protein-coding genes significantly regulated during
neurogenesis (Fig. 3D). That these lncRNAs are bona fide regulated
transcripts is further supported by specific splicing, which was
observed for several of the neurogenic lncRNAs (Fig. 3E, Fig. S8).
Thus, these lncRNAs are unlikely to be merely by-products of
spurious transcription; rather, they are subject to regulated
expression, RNA processing, and controlled export, which
supports a potential role in neurogenesis.
One intriguing example of a lncRNA demonstrating specific
expression over the course of early neurogenesis is CR30009. This
lncRNA showed increased expression in the early intermediate
column and in neuroblasts, but was most highly enriched in glial
cells during all assayed time windows (Fig. 3A). Furthermore,
CR30009 is spliced and primarily exported to the cytoplasm
(Fig. 3C,E), features indicative of specific co- and post-
transcriptional regulation. However, CR30009 has the lowest
coding potential out of all tested lncRNAs: its PhyloCSF score
per codon (−42.647) was more than three standard deviations below
the mean for noncoding regions in Drosophila (−18.7±7.2,
Fig. 3B). Furthermore, CR30009 is one of the most highly
abundant transcripts in glia – noncoding or protein-coding (log2
maxTPM=15.75, Fig. 3D, Table S3) – which underscores the
potential functional importance of CR30009 in gliogenesis.
Notably, this lncRNA appears to exist predominantly as an
unannotated short isoform and exhibits regions of high noncoding
sequence conservation among drosophilids within the first exon and
at the 3′ end of the transcript (Fig. 3E).
A second example, CR43283 (also known as cherub), exhibited
dynamic temporal regulation. Expression of cherub was strongly
enriched in the earliest neuroblasts at 4-6 h, but enrichment quickly
waned in later neuroblasts (6-8 h); however, over time cherub
became specifically expressed being strongly enriched in
differentiated neurons and glia by the end of neurogenesis at 18-
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22 h AEL (Fig. 3A). We note that enriched expression of the
lncRNA in Elav- and Repo-negative samples may be caused by
cherub-positive glia in the neuron-depleted fraction and cherub-
positive neuroblasts/neurons in the glia-depleted fraction. cherub
was also specifically localized to the cytoplasm throughout
embryogenesis and is clearly spliced, but harbors no coding
potential (Fig. 3B,C, Fig. S8D).
CR32730 was first detected in 4-6 h neuroblasts and was
moderately enriched at 8-10 h in the neuronal, but not in the glial,
population (Fig. 3A). CR32730 is transcribed antisense to the intron
of CG9650 (Fig. S8C), a putative neurogenic transcription factor
that has been implicated in CNS development (McGovern et al.,
2003). However, CR32730 appears to be transcribed independently
of CG9650, which was expressed at low levels in early neuroblasts
according to DIV-MARIS (Fig. S8C), suggesting that their roles
could be independent. Fractionation-Seq predicts that CR32730 is
moderately enriched in the nuclear fraction in early and late embryos
(Fig. 3C).
Expression of another lncRNA, CR46003, was first detected in
the ventral column and was most highly enriched in early
neuroblasts, but expression persisted in neuroblasts and early
neurons (Fig. 3A). CR46003 was one of the most abundant
lncRNAs in our dataset and did not exhibit clear subcellular
enrichment in either early or late embryos (Fig. 3C,D). Intriguingly,
the transcription start site of CR46003 is antisense to CR46004,
which contains a miRNA implicated in behavior (Picao-Osorio
et al., 2017) (Fig. S8B).
CR44024 expression was first enriched in early neuroblasts and
persisted through neuronal differentiation, and is predicted to be
excluded from the intermediate and ventral columns and glia
(Fig. 3A). This lncRNA is not predicted to exhibit distinct
subcellular localization in early (6-8 h) embryos, but was
moderately enriched in the cytoplasm at the end of embryogenesis
(18-22 h, Fig. 3C). CR44024 was also one of the highly expressed
lncRNAs in our dataset with expression on a par with protein-
coding genes (Fig. 3D). The transcript is intergenic, and appears to
be spliced, although not in accordance with its annotated transcript
model (Fig. S8E).
In summary, DIV-MARIS predicted spatiotemporal expression
of a number of lncRNAs during neurogenesis. Through the
application of stringent criteria, we refined this list to a high-
confidence selection of noncoding transcripts with diverse predicted
expression patterns and properties. To confirm these predictions for
several lncRNA candidates, we first visualized their expression in
the context of a whole developing embryo.
Neurogenic lncRNAs mark specific neuroglial subsets
To visualize lncRNA expression, we performed multiplex RNA
fluorescent in situ hybridization (RNA-FISH; Kosman et al.,
2004) against the five examples discussed above (CR30009,
Fig. 3. Neuroglial lncRNAs are highly regulated
transcripts. (A) Row mean-centered expression values
of lncRNAs in marker-enriched and -depleted samples
(scale=log2 ratio of row mean, gene level VST).
(B) PhyloCSF scores (ScorePerCodon) for the putative ORF
with the highest coding potential within each transcript. Scale
is from ∼1 s.d. above the mean score of coding regions (very
high coding potential) down to ∼1 s.d. below the mean of
noncoding regions (very low coding potential). (C) Row
mean-centered expression profiles in 6-8 h and 18-22 h
embryo nuclear and cytoplasmic fractions generated by
Fractionation-Seq; values as in A. (D) Violin plot showing
distribution of maximum TPM (maxTPM) values for
all lncRNAs (red; n=325) and mRNAs (gray; n=3835)
differentially expressed (log2FC>1.0, Padj<0.05) between
any marker-positive and marker-negative cell type; lncRNAs
presented in A are highlighted. (E) CR30009 genomic locus
showing stranded RNA-seq data from sorted glia at 6-8 h
AEL (negative strand; blue), overlay of smoothed PhyloCSF
scores of individual codons in each of three frames
(horizontal line is 0), and conservation among drosophilids
(phastCons).
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cherub,CR46003,CR32730 andCR44024) together with neurogenic
marker genes. Remarkably, RNA-FISH revealed exquisite
spatiotemporal specificity of lncRNA expression for each of the
lncRNAs tested.
CR30009 – predicted by DIV-MARIS to be highly enriched in
glia – was indeed co-expressed with repo as expected in clusters of
glial cells as early as stage 9/10 (Fig. 4A,B, Fig. S9). CR30009
remained co-expressed with most repo-expressing cells through stage
13/14 (Fig. 4C,D). However, timing ofCR30009 expression suggests
it to be independent of repo, indicating that this lncRNA constitutes
an earlier marker of the glial lineage than currently known. Although
most repo-positive cells also expressed CR30009 in stage 9-12
embryos, the lncRNA was largely expressed in small puncta within
other cells in the ventral nerve cord and brain that are likely to be
neuroblasts (Fig. 4A,B, Fig. S9). Accordingly, DIV-MARIS predicts
CR30009 expression in 4-6 h and 6-8 h pros-positive cells (Fig. 3A,
Fig. S10). It is feasible, therefore, that the lncRNA CR30009
constitutes the earliest neuroblast marker of the glial lineage identified
to date, which accumulates into larger, brighter foci during early
phases of glial differentiation (Figs S9, S10).
RNA-FISH against the lncRNA cherub revealed strong
spatiotemporal regulation of cherub broadly in accordance with
DIV-MARIS, which predicted cherub to be strongly and
specifically enriched in early (4-6 h) neuroblasts, and late
(18-22 h) neurons and glia (Fig. 3A). We observed clear
induction of cherub expression within six small clusters of cells
in the ventral nerve cord during stage 12, each of which also
expressed pros (Fig. 5A) and to a lesser degree, elav (Fig. 5B); both
of these observations are in line with cherub constituting a
neuroblast marker. During stage 13, cherub was seen in several
additional clusters in the brain (Fig. 5B, Fig. S11A,B). By stage 14-
15, cherub was very strongly expressed in multiple defined pros
neuroblast clusters, but appeared to be excluded from mature
neurons and glia (Fig. 5C,D, Figs S11C,D, S12), and remained
strongly expressed through the remainder of embryogenesis (stage
16/17, Fig. S12B), in line with DIV-MARIS predictions (Fig. 3A).
Fig. 4. The lncRNA CR30009 is expressed in glial subsets. RNA-FISH
against CR30009 and the glial marker repo. (A) Lateral view, stage 11/12.
(B) Ventral view, stage 11/12. (C) Lateral view, stage 13. (D) Ventral view; stage
13/14. Top: CR30009 alone; below: merge of CR30009 (magenta) with repo
(green). Second from bottom: enlargement of the region of interest (ROI)
indicated by the dotted white box. Bottom: Slice through z-stack at the level
indicated by the yellow line. Embryos are∼500 µmalong the long axis, oriented
anterior leftwards and ventral downwards in lateral views.
Fig. 5. The lncRNA cherub is expressed with strict spatiotemporal
specificity primarily in a subset of neuroblasts. RNA-FISH against cherub,
the neuroblast marker pros and the neuronal marker elav. Ventral views.
(A) cherub with pros; stage 12. (B) cherub with elav; stage 13. (C) cherub with
pros; stage 15. (D) cherubwith elav; stage 14. Top: cherub alone. Second from
top: cherub (magenta) overlaid with marker (green). Second from bottom:
enlargement of the region of interest (ROI) indicated by the dotted white box.
Bottom: Slice through z-stack at the level indicated by the yellow line. Embryos
are ∼500 µm along the long-axis, oriented anterior leftwards.
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DIV-MARIS predicts similar spatiotemporal expression of
CR46003 and CR32730 in neuroblasts and neurons (Fig. 3A).
Indeed, RNA-FISH revealed very similar patterns of expression of the
two lncRNAs. CR46003 exhibited the earliest expression of all
lncRNAs tested here and is was in a small cell cluster already at stage
5-6 (Fig. S13). By stage 9-10, punctate expression of CR46003
appeared in defined pros-expressing clusters along the embryonic
ventral midline (Fig. 6A), in agreement with the DIV-MARIS-
predicted enrichment in cells of the ventral column and neuroblasts at
4-6 and 6-8 h AEL (Fig. 3A). CR46003 expression expanded to a
greater number of cells within and beyond the ventral nerve cord and
brain from stage 11-13, many of which also expressed pros (Fig. 6B,
Fig. S14A-C) and some expressed elav as well (Fig. S15). As
predicted by DIV-MARIS, RNA-FISH demonstrated that CR32730
follows a very similar pattern of expression to CR46003 from stage
9-10 to stage 13 (Fig. 6, Fig. S14).
Although we were not able to detect the transient CR44024
expression in early (stage 9-10) pros-positive neuroblasts as predicted
by DIV-MARIS, we did observe that this lncRNA exhibits highly
dynamic temporal regulation. At stage 12, CR44024 was induced
within small elav-positive clusters flanking the midline (Fig. S16).
Starting at stage 13, CR44024was expressed much more broadly, yet
was still restricted to subsets of elav- and pros-expressing cells within
the ventral nerve cord and central brain (Fig. 7).
Lastly, we assessed the subcellular localization of individual
lncRNAs. For example, Fractionation-Seq (Fig. 3C) predicted
CR30009 and cherub to be predominantly cytoplasmic. This is
supported for both lncRNAs by high-resolution confocal
microscopy, as both transcripts were primarily detected in the
cytoplasm (Fig. S17A,B). CR46003 and CR32730 both showed a
slight bias for nuclear localization by Fractionation-Seq, which was
confirmed by microscopy as both lncRNAs were clearly stained
within the nucleus, though it should be noted that subnuclear puncta
were observed (Fig. S17C,D). Similarly, CR44024 appeared to be
restricted primarily to the nucleus in the ventral nerve cord at stage
14 (Fig. S17E), matching the prediction.
Fig. 6. The lncRNAs CR46003 and CR32730 are expressed with similar
spatiotemporal specificity in a subset of neuroblasts. RNA-FISH against
CR46003 and CR32730 together with the neuroblast marker pros. Ventral
views. (A) CR46003; stage 9. (B) CR46003; stage 11/12. (C) CR32730;
stage 10. (D) CR32730; stage 11/12. Top: lncRNA alone. Second from
top: lncRNA (magenta) overlaid with pros (green). Second from bottom:
enlargement of the region of interest (ROI) indicated by the dotted white box.
Bottom: Slice through z-stack at the level indicated by the yellow line. Embryos
are ∼500 µm along the long axis, oriented anterior leftwards.
Fig. 7. The lncRNA CR44024 is expressed later in embryogenesis in
neuronal subsets. RNA-FISH against CR44024, the neuroblast marker pros
and the neuronal marker elav. (A) CR44024 and elav; lateral view; stage 13.
(B) CR44024 and pros; lateral view; stage 13. (C) CR44024 and elav; ventral
view; stage 14. (D) CR44024 and pros; ventral view; stage 14. Top: CR44024
alone. Second from top: CR44024 (magenta) overlaid with marker (green).
Second from bottom: enlargement of the region of interest (ROI) indicated by
the dotted white box. Bottom: Slice through z-stack at the level indicated by the
yellow line. Embryos are ∼500 µm along the long axis, oriented anterior
leftwards and ventral downwards in lateral views.
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The identification of such complex, yet specific, expression
patterns highlights the importance of tissue- and cell type-specific
expression analysis. Whole embryo studies, for example, not only
lack spatial resolution, but expression signatures – even of highly
expressed genes – may be lost if their expression is specific to a
small-enough subset of cells. Here, we provide a map for the cell
type-specific expression of coding, as well as noncoding, RNAs
over the course of embryonic neurogenesis in the developing
Drosophila embryo. Although hundreds of coding and dozens of
lncRNAs are deployed with specific spatial and temporal dynamics,
it should be noted that direct imaging of expression within a spatial
context can reveal nuances of expression that is beyond the
resolution of many cell type-specific genomic approaches.
DISCUSSION
Complex tissues are defined by the intricate interplay of individual
cell types that differ in their gene expression programs. Tissue
culture has long been an important tool for the genome-wide
investigation of cellular responses as it avoids much of the
heterogeneity inherent to living tissues. Unfortunately, it is often
precisely this heterogeneity and the dynamic contacts between cells
and tissues that shape cellular identities and transcriptomic
responses. Hence, to determine the gene regulatory programs that
drive complex organismal development, it is crucial to (1) preserve
the cellular interactions in vivo, (2) acquire genome-wide
transcriptomic data with spatial and/or cell-type resolution, and
(3) assure temporal resolution.
DIV-MARIS to investigate global cell type-specific gene
expression dynamics
To investigate the transcriptome dynamics over the course of
neurogenesis from primordial to neuronal and glial identities, we
developed a method of isolating specific cell types fromDrosophila
embryos with resolution in time and space. DIV-MARIS is widely
applicable and can be employed for spatiotemporal transcriptional
profiling of basically any cell type of interest in the Drosophila
embryo and other complex tissues, as long as markers allowing for
sorting a cell type of interest are available (i.e. appropriate
antibodies or transgenic markers e.g. enhancer-reporter
constructs). DIV-MARIS employs chemical cross-linking of the
cellular material, thus ensuring that the developmental status quo is
preserved, and elaborate sorting strategies based on multiple
markers, which could be devised to fine-tune the sub-population
selection one wishes to purify (Molyneaux et al., 2015).
Here, we purified fixed cells based on markers of specific
neurogenic cell populations in the early Drosophila embryo. DIV-
MARIS faithfully resolved known expression patterns of
neurogenic protein-coding genes, but also identified cell type-
specific expression of additional genes with yet unknown
neurogenic functions; neuroglial expression was confirmed by
in situ hybridization for a few dozenmRNAs, but hundreds more are
predicted to exhibit spatiotemporal expression over the course of
early neurogenesis. This compendium lays the groundwork for a
comprehensive understanding of the mechanisms driving early
neurogenesis and, given that many of the spatiotemporally
expressed genes encode regulatory factors such as transcription
factors and signaling molecules, careful examination of their
neurogenic roles will be required.
Identification of spatiotemporal lncRNA expression
This study has identified many cell type-specific lncRNAs with
potential neurogenic function. We emphasize that this is not yet an
exhaustive list of lncRNAs expressed in the nervous system, as our
filtering criteria were conservative. Instead, we focused on a high-
confidence set of 13 lncRNAs with a variety of expression and
transcript characteristics. Given that these noncoding transcripts are
(1) temporally expressed in specialized cell types and subtypes of
the nervous system, (2) moderately-to-highly abundant and (3) often
exhibit hallmarks of RNA processing (such as splicing and nuclear-
cytoplasmic shuttling), these lncRNAs appear to be subject to
regulated expression rather than being by-products of spurious
transcription.
Notably, we did not identify any lncRNAs with expression
restricted to the early neuroectodermal columns. According to DIV-
MARIS, there is some enrichment of CR30009 in the intermediate
column and CR46003 in the ventral column (Fig. 3A), but as the
respective territorial markers of the ventral and intermediate columns
are still detectable in the neuroblast progenitors, this expression may
be specific to neuroblasts, in which higher enrichment is observed.
High and specific lncRNA expression appears to be a feature of
differentiating and differentiated cell types of the nervous system,
rather than of primordial territories.
Multiplex RNA-FISH shows that lncRNAs often exhibit a high
degree of cell-type specificity. Though co-expression was generally
detected with cell type-specific markers, as predicted by DIV-
MARIS, we could observe much more nuanced spatiotemporal
lncRNA regulation than we could have predicted – the noncoding
transcripts investigated here tended to be expressed in highly specific
subsets of neurogenic cell types (Figs 4–7). It is therefore feasible that
these lncRNAs perform highly specialized functions in subsets of
cells contributing to discrete regions of the nervous system.
For example, CR46003 and CR32730 are the first lncRNAs that
appear to specifically mark midline and midline-proximal structures
(Fig. 6, Fig. S14). Given the midline’s highly specialized role as a
signaling and organizing center (Wheeler et al., 2006; Crews, 2010;
Zhou et al., 1995), it is intriguing to speculate that such lncRNAs
may help shape the midline fates. Although lncRNAs were enriched
in a variety of neurogenic populations, CR30009 was consistently
and highly enriched in repo-positive glia and to some degree in
pros-expressing neuroblasts (Fig. 4, Figs S9, S10). It is feasible that
CR30009 may play a role in the priming of glial fates from the
earliest stages of differentiation, possibly mediating the transition
from neuroblasts and GMCs to specifically the glial fate. As most
glia in the Drosophila embryonic CNS originate from the lateral
column, it will be of interest to determine whether CR30009
expression and function are limited to glia of the lateral neurogenic
ectoderm, or present in ventral column-derived glia as well.
Are these lncRNAs functional? cherub serves as a nice example
arguing that several of them likely are. The lncRNA cherub was
recently identified as a highly upregulated transcript in neuroblast-
derived tumors in larvae (Landskron et al., 2018). In larvae, cherub
is asymmetrically inherited by the self-renewing neuroblast to allow
fate progression of the sibling cell and cherub’s specific predicted
enrichment in embryonic neuroblasts (Fig. 3A) indicates that this
lncRNA could exhibit a similar function in the early embryo.
However, the precise temporal regulation of cherub was surprising,
as RNA-FISH identified its presence not in early, but in
differentiating and fully differentiated neurons and glia by the end
of embryogenesis (Fig. 5, Figs S11, S12).
Intricate spatiotemporal expression regulation is a hallmark of
many lncRNAs (Wilk et al., 2016; Karaiskos et al., 2017; Landskron
et al., 2018). Various lncRNAs have been demonstrated to play
diverse biological roles – nuclear and cytoplasmic – from integral
parts of riboprotein complexes, to regulating dosage compensation,
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to affecting genome topology. lncRNA complexity has been
reported to be especially pronounced in the nervous system
(Briggs et al., 2015; Molyneaux et al., 2015) and even early
stages of embryonic neurogliogenesis appear to be no exception.
However, the challenge clearly remains to unravel the neurogenic
roles of these putative noncoding regulators, and the molecular
mechanisms by which they act. This study represents a valuable
resource for understanding transcriptome complexity in the
emerging nervous system and it lays the basis for further studies
into the mechanisms by which noncoding genes, but also hundreds




For details of fly strains and husbandry, see supplementary Materials and
Methods.
FACS purification and RNA isolation using DIV-MARIS
Briefly, embryos were dissociated into single-cell suspensions, and cells
were fixed in 4% formaldehyde. Fixed cell suspensions were
immunostained under RNase-free conditions and FACS-purified using a
FACS-AriaII cell sorter (BD Biosciences). Marker-enriched and -depleted
cell populations were collected in biological duplicates. FACS-purified cells
were subject to cross-link reversal and proteinase K digestion prior to RNA
isolation. Additional experimental details for DIV-MARIS are provided in
the supplementary Materials and Methods; primary and secondary
antibodies used in this study are listed in Table S6.
Nuclear-cytoplasmic fractionation
Cytoplasmic and nuclear extracts were isolated fromwholeDrosophila embryos
by detergent-based hypotonic lysis for RNA isolation. Additional experimental
details are provided in the supplementary Materials and Methods.
Quantitative RT-PCR (qPCR)
qPCR was performed using standard SYBR Green, with the Bio-Rad
CFX96 Touch Real-Time PCR Detection System. Additional information is
available in the supplementary Materials and Methods; qPCR primer
sequences are listed in Table S7.
Library preparation and RNA-sequencing
All RNA-seq libraries were constructed using the NuGEN Ovation
Drosophila RNA-Seq System with 10-100 ng total RNA input. Library
concentration was quantified using the Qubit dsDNA HS Assay (Thermo
Fisher Scientific, Q32854) and quality was determined on a BioAnalyzer
using Agilent High Sensitivity DNA Kits (Agilent, 5067-4626). All
libraries were sequenced on the Illumina HiSeq4000 at a mean depth of 62.5
million 75 bp paired-end reads per sample. RNA-seq datasets generated for
this study are detailed in Tables S10 and S11.
Bioinformatic analysis of RNA-seq data
Sequencing files were demultiplexed using bcl2fastq (v2.19, Illumina), and
quality determined using FastQC (https://www.bioinformatics.babraham.ac.
uk/projects/fastqc/). A genomic reference index for Drosophila
melanogaster was constructed with RSEM using the most recent genome
build (BDGP release 6) and transcriptome annotation (Release 6.15)
obtained from Flybase (www.flybase.org). Annotations used for lncRNAs
have been described by Young et al. (2012). Paired-end reads were pseudo-
aligned to the RSEM reference index using Salmon (Release 0.8.1) using the
following parameters: $ salmon quant –libType ISF –seqBias –gcBias –
posBias -p 8 –numBootstraps 100.
Gene-level counts were prepared for differential expression analysis with
tximport as part of the Bioconductor package (Release 3.5). Feature length-
scaled TPM values were calculated with tximport using the following
command: >tximport(files, type=“salmon”, countsFromAbundance=
“lengthScaledTPM”, tx2gene=tx2gene).
Given the cell-type heterogeneity between samples in this dataset, we
used normalized counts instead of TPM or FPKM for more accurate inter-
sample comparisons of gene abundance. We normalized gene-level counts
via variance stabilizing transformation (Table S1). Variance-stabilized
transformed counts, principal component analysis, and differential
expression were calculated using DESeq2 (Love et al., 2014) as part of
the Bioconductor package (Release 3.5), using default parameters.
PhyloCSF
PhyloCSF uses substitutions and codon frequencies in a genome alignment
of 23 drosophilid species to distinguish the evolutionary signature of
selection for protein-coding function (Lin et al., 2011). For each transcript,
PhyloCSF generates a score for the putative open reading frame (ORF) with
highest coding potential; transcripts with positive scores are more likely to
be protein coding. The candidate ORFs, their PhyloCSF scores, and other
related information are included in Table S5.
Briefly, local alignments used for PhyloCSF were extracted from the 23-
drosophilid subset of the 27-wayMULTIZ insect whole-genome alignments
(Blanchette et al., 2004), downloaded from UCSC: http://hgdownload.soe.
ucsc.edu/goldenPath/dm6/multiz27way/ (Tyner et al., 2017). PhyloCSF
scores were computed using the 23flies parameters with the options ‘-f3
--orf=ATGStop --allScores --bls’, which computes the score of every ORF
within the transcript that begins with ATG, is followed by a stop codon, and
is at least the default length of 25 codons. Because CR44272 has no putative
ORFs that long, we used ‘--minCodons=19’ to lower the threshold for that
gene to the length of its longest putative ORF. We then selected the ORF in
each transcript having the highest PhyloCSF score. The reported
‘ScorePerCodon’ is the PhyloCSF score divided by the number of codons
in the putative ORF. To identify potential cases in which one of the
transcripts under consideration contains part of a coding ORF but the
complete ORF is in an unidentified overlapping transcript, we also ran
PhyloCSF using the --orf=StopStop3 option, with --minCodons=10, which
looks for ORF fragments ending in a stop codon. However, that did not
identify any plausible partial coding ORFs. The PhyloCSF track images in
Fig. 3 and Fig. S6 are overlays of the ‘Smoothed PhyloCSF’ tracks in all
three frames on the appropriate strand, from the PhyloCSF track hub in the
UCSC genome browser, documented at: https://data.broadinstitute.org/
compbio1/PhyloCSFtracks/trackHub/hub.DOC.html.
Generation of coverage plots
The strand-specific and paired-end RNA-seq reads were mapped to the
Drosophila melanogaster reference genome dm6 with the splicing-aware
mapper STAR v2.5.3a (Dobin et al., 2013) using default parameters and a
Drosophila-specific adjustment for maximum intron length and mate
distance of 50 kb. The resulting BAM files were filtered to include only
uniquely mapping read pairs and then converted into strand-specific genome
coverage tracks in BigWig format for visualization in the UCSC genome
browser (Kent et al., 2010; Raney et al., 2014) using the stranded-coverage
(https://github.com/pmenzel/stranded-coverage) and wigToBigWig from the
UCSC genome browser tools.
Immunohistochemistry and FISH
Immunohistochemistry and RNA-FISH were performed as previously
described (Kosman et al., 2004; Karaiskos et al., 2017). Primary and
secondary antibodies used in this study are listed in Table S6. The procedure
for probe synthesis is detailed in supplementary Materials andMethods, and
RNA probes are listed in Tables S8 and S9.
Microscopy
Confocal stacks were imaged at BIMSB/MDC using a Leica SP8 equipped
with 405 nm laser diode, white light laser, and hybrid detectors, with a
20× glycerol objective. For each field of view, 65-85 slices were
acquired using ∼AU=1 pinholes and taking care not to saturate signal.
Appropriate slices were maximum intensity projected. Imaging work at the
BioFrontiers Institute’s Advanced Light Microscopy Core was carried out
on either a Nikon A1R laser scanning confocal microscope (NIST-CU
Cooperative Agreement 70NANB15H226) or on a Nikon Ti-E spinning
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disc confocal microscope (BioFrontiers Institute, Howard HughesMedical
Institute).
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Supplementary Materials and Methods
Fly strains and husbandry 
Drosophila melanogaster lines used in this study include 
yellow-white y1 w1118   (source: BSC# 6598) 
IC-GFP y1 w1118 ; ; P{3xind_1.4-GFP}  (this study) 
IC-dsRed y1 w1118 ; P{3xind_1.4-dsRed} (this study) 
VC-dsRed y1 w1118 ; ; P{2xvnd_743-dsRED} (Karaiskos et al. 2017) 
vnd-lexA/VC:FNLDD y1 w1118 ; M{3xvnd-lexA:Cit}attP_ZH51C ; P{vnd:FNLDD} (Krueger et al., 
unpublished) 
rho-lexA/VC:FNLDD y1 w1118 ; M{3xrho-lexA:Cit}attP_ZH51C ; P{vnd:FNLDD} (Krueger et al., 
unpublished) 
The IC-GFP and IC-dsRed lines were created by standard P-element transgenesis (Rubin & Spradling 
1982) in a y1 w1118 background. The ind enhancer (ind_1.4) (Markstein et al. 2004) was cloned using 
primers (ngctagcgtcgacGCTTCAAAGCTCCGGGAAACG & nctcgagTCTGGGCCTTCGGTCCGAAAATG) 
flanked with NheI and SalI restriction sites (F primer) and with XhoI (R primer). PCR product was T/A 
cloned into pCRII-Duo and concatemerized using the compatibly cohesive sites XhoI and SalI. 3x ind_1.4 
constructs were directionally subcloned into the P-element vectors pH-Stinger or pRed-HStinger (Barolo 
et al. 2004) using NheI and XhoI. 
Fly stocks were maintained at 25°C, ~60% relative humidity on standard fly food with 12 hr light/dark 
cycles according to standard procedures. 2-hr embryo collections were done on apple juice agar plates 
with yeast paste after 3 x 1hr pre-lays in the morning, embryos were then aged for an appropriate amount 
of time at 25°C and ~60% relative humidity before dechorionation. 
DIV-SortSeq
This protocol incorporates portions from MARIS (Hrvatin et al. 2014). All steps after dechorionation were 
performed on ice, using ice-cold DEPC-treated solutions. Primary and secondary antibodies used in this 
study are listed in Table S1. RNase-free BSA was obtained from Gemini Bioproducts and is critical for 
isolation of high-quality RNA. 
Embryos were collected, dechorionated, and dissociated into single-cell suspension in 15ml PBS, pH 7.5 
using 8-12 strokes with the loose pestle of a glass dounce homogenizer. Large debris was removed via 
filtration with 2 x 90°-rotated sheets of Miracloth into a 15ml conical vial, followed by centrifugation at 
40xg, 4°C, 3 min. The supernatant was transferred to a 15ml conical vial, cells were pelleted at 1000xg,  
4°C, 3 min, washed with 1ml PBS, and fixed with 4% formaldehyde at 4°C, 15min. Cross-linking was 
stopped with Quench Buffer (2.5M Glycine in PBS). Fixed cells were washed twice with 1ml ice-cold PBS, 
and stored at 4°C overnight in 1ml RNAlaterTM (Thermo, AM7020). Cells were rehydrated via dilution in 
9ml ice-cold PBS, centrifugation at 1000 xg, 10min, and washed twice in 1ml ice-cold PBS. Fixed cell 
suspensions were immunostained under RNase-free conditions with primary antibodies with agitation at   
4 °C, 1.5-2h in 250µl Stain Buffer (1% BSA (w/v), 0.1% saponin, 1:200 RNase inhibitor in RNase-free





















PBS). After washing 3x 5 min in 1ml Wash Buffer (0.2% BSA, 0.1% saponin in PBS), cells were incubated 
with conjugated secondary antibodies with agitation at 4C, 45 min-1h in 250µl Stain Buffer. After washing 
3x 5 min in 1ml Wash Buffer, cells were resuspended in 1ml Sort Buffer (0.5% BSA, 2mM EDTA, 1:500 
RNase inhibitor in PBS) and filtered with a 70µm cell strainer. Filtered cells were subjected to FACS 
purification on the FACSAria II (BD Biosciences) and sorted cells collected in Collection Buffer (2% BSA, 
1:100 RNase inhibitor in PBS).  
FACS-purified cells were pelleted and resuspended in 200µl Digestion Buffer (5M NaCl, 1M Tris-HCl pH 
8.0, 200mM EDTA, 10% SDS, 3.2U Proteinase K, 1:100 RNase inhibitor) and incubated at 50°C, 15min 
(Proteinase K digestion) followed by 80°C, 15min (reversal of formaldehyde cross-links). Samples were 
transferred to ice and resuspended in 600µl TRIzol LS Reagent (Thermo, 10296028). RNA was isolated 
using the DirectZol RNA MicroPrep Kit (Zymo Research, R2060) according to the manufacturer’s 
instructions. RNA concentration was measured using the Qubit RNA HS Assay kit (Thermo, Q32852) 
and RNA quality determined using the Agilent RNA 6000 Pico Kit (Agilent, 5067-1513). All RNA-seq 
libraries were constructed using the NuGEN Ovation Drosophila RNA-Seq System with 10 ng – 100 ng 
total RNA input. Library concentration was quantified using the Qubit dsDNA HS Assay (Thermo, 
Q32854) and quality was determined on a BioAnalyzerTM using Agilent High Sensitivity DNA Kits (Agilent, 
5067-4626). All libraries were sequenced on the Illumina HiSeq4000 at a mean depth of 62.5 million 75bp 
paired-end reads per sample. RNA-seq datasets generated for this study are detailed in Tables S5 and 
S6. A detailed, step-wise protocol is available upon request. 
Nuclear-cytoplasmic fractionation 
The cell fractionation procedure incorporates portions from MARIS (Hrvatin et al. 2014). All steps were 
performed on ice, using ice-cold DEPC-treated solutions, and all centrifugation steps were performed at 
4˚C. Embryos were processed to single-cell suspension as described above for DIV-SortSeq, then 
pelleted and resuspended in Cyto Extract Buffer (20mM Tris pH 7.6, 0.1mM EDTA, 2mM MgCl2). After 
hypotonic swelling, cells were gently lysed by addition of 0.6% CHAPS for isolation of t he cytoplasmic 
fraction. Nuclei were pelleted at 500xg for 5min, and the supernatant retained, and an appropriate volume 
of TRIzol LS Reagent was added (cytoplasmic fraction). 
Nuclei were washed with Nuclei Wash Buffer (20mM Tris pH 7.6, 0.1mM EDTA, 2mM MgCl2, 0.6% 
CHAPS), resuspended in Nuclei Resuspension Buffer (10mM Tris, pH 7.6, 150mM NaCl, 0.15% NP-40) 
and pelleted at 12,000xg, 10min in Sucrose Buffer (10mM Tris, pH 7.5, 150mM NaCl, 24% sucrose). After 
washing (1mM EDTA in PBS), nuclei pellet was resuspended in TRIzol Reagent. RNA was isolated and 
concentration and quality determined as described for above for DIV-SortSeq. 
Quantitative RT-PCR (qPCR) 
50ng of total RNA was reverse-transcribed with the QuantiTect Reverse Transcription kit (Qiagen, 
205310) in a total volume of 20µl, according to the manufacturer’s instructions. For each gene, 0.2µl 





















cDNA was used for input into qPCR using SensiFAST™ SYBR® No-ROX Kit (Bioline, 98020) and 5µM 
forward and reverse primers in a total volume of 20µl. qPCR primer sequences are listed in Table S2. 
qPCR thermal cycling and fluorescent data acquisition was performed using the BioRad CFX96 Touch 
Real-Time PCR Detection System. Expression fold changes were calculated via the ∆∆CT method 
(Vandesompele et al. 2002; Schmittgen & Livak 2008), normalized to the mean CT of two reference 
genes: α-tubulin and actin 42A. 
RNA probe design and synthesis for RNA in situ hybridization. 
Where available, cDNA clones were obtained from the Drosophila Gene Collection or Drosophila 
Genomics Resource Center (Stapleton et al. 2002), detailed in Table S3. Constructs were linearized via 
restriction digestion, and subjected to in vitro transcription using appropriate RNA Polymerases (Roche), 
using ribonucleotide mixtures containing dUTP-DIG, -FITC, or -Biotin (Roche).  
Where cDNA clones were not available, PCR primers were designed to amplify a region within the 
transcribed locus from genomic DNA. Primer sequences are detailed in Table S4. A T7 promoter 
sequence appended to the reverse primer allowed in vitro transcription directly from the PCR product. 
After template digest by DNaseI, RNA probes were sheared at 65°C for 3-20 min in carbonation buffer 
(120mM Na2CO3, 80mM NaHCO3, pH 10.2), length of carbonation depended on probe length. RNA 
probes were precipitated at -20°C overnight and resuspended in Hyb-A Buffer (50% formamide, 5X SSC, 
0.1% Tween-20). 





















Table	S1. VST counts by gene across datasets 
Click here to Download Table S1
Table	S2. Neurogenic coding genes 
Click here to Download Table S2
Table	S3. Enriched lncRNAs 
Click here to Download Table S3























Click here to Download Table S4
Table	S5. PhyloCSF analysis 
Click here to Download Table S5
































Intervals of the input transcript 
Strand 
Name from the input bed file 
Link to show the entire transcript in UCSC browser 
Intervals of the ORF (not including the stop codon) 
0-based transcript coordinate of first base of ORF 
0-based transcript coordinate of last base of ORF 
Number of codons in the ORF 
Raw PhyloCSF score of the ORF 
Fraction of branch length of the phylogenetic tree spanned by species present in 




PhyloCSF divided by NumCodons 
Length adjusted score, a log likelihood, in decibans 
Probability a region of this length, none-of-which has ever been coding, has this 





p-val with Holm-Bonferroni correction for number of ORFs in this transcript 
p-val with Holm-Bonferroni correction for total number of ORFs 
Benjamini & Hochberg false discovery rate. 
Local FDR (Efron et al. 2001). 




ScorePerCodon - AntiScorePerCodon 
GC content of ORF 




Link to view ORF alignment in CodAlignView, the Codon Alignment Viewer, with 
10-codon context on each side 
Link to show the ORF in UCSC browser 
Table S6: Primary and secondary antibodies used in this study 
Target Supplier Catalog # Application Antibody Type Conjugate Dilution 
RFP Thermo 710530 Primary Rabbit polyclonal N/A 1:500 
GFP Thermo G10362 Primary Rabbit polyclonal N/A 1:500 
Pros DSHB MR1A Primary Mouse 
monoclonal 
N/A 1:20 
Elav DSHB 9F8A9 Primary Mouse 
monoclonal 
N/A 1:500 





Thermo A21428 Secondary Goat polyclonal Alexa Fluor 555 1:500 
Mouse 
IgG 
Thermo A32727 Secondary Goat polyclonal Alexa Fluor 555 1:500 
Table S7: qPCR primer sequences 
Target Forward primer Reverse primer Size (bp) 
α-Tubulin TGTCGCGTGTGAAACACTTC AGCAGGCGTTTCCAATCTG 585 
Actin 42A GCGTCGGTCAATTCAATCTT AAGCTGCAACCTCTTCGTCA 292 
Prospero CGGCATGGCTCCTACTTCTT TAGCGCACCCAGAAGAACAT 78 
Worniu ATGGATAAACTCAAGTACAGCCG AAGTCCACTGGTCCTTCATCA 107 
Elav ACGCTCCTGCCACAGAAAAA CGTCGCCGTATTTCGCTC 211 
Lim3 GATGGAGGATCGTAAGCTGATCT GTAGGCCGTTTTCAGGGTCTC 154 
Repo CTCCGCCAAGTAGTTCCTCC AGGCAGTAAAGGTGGTTCTCG 216 
Gcm ACAAGGCCAGAAGGAAGCAG CAAGCCTGGATTTCCAAGCGA 76 





















Table S8: List of commercially-available cDNA clones for RNA probe synthesis 










Table S9: PCR primer sequences for RNA probe synthesis 
Target Forward primer T7 promoter + Reverse primer Size 
(bp) 
CR46003 TGTGTCGCACAGGATGTGT TAATACGACTCACTATAGGTGCTGGCGGGGAAATTATGT 908 
cherub CGAGGAACCTTCGGTGCATA TAATACGACTCACTATAGGGCTTGGGTGATTTCGAGGGA 1511 
CR44024 GTGTCGTGTCGGGTAAGTGT TAATACGACTCACTATAGGAAGTGGCCTGTCTCAGAACG 1268 
CR32111 GTATGCGCTCGAACTCGGTAA TAATACGACTCACTATAGGGCCGGCATGAGCAAACACAAA 1232 





















Table S10: Summary of RNA-seq datasets – DIV-SortSeq 












4-6h_Ind-neg_1 IC-dsRed dsRed 
Intermediate 
column 
Depleted 4-6h 1 89.9 
4-6h_Ind-neg_2 IC-dsRed dsRed 
Intermediate 
column 
Depleted 4-6h 2 140.1 
4-6h_Ind-pos_1 IC-dsRed dsRed 
Intermediate 
column 
Enriched 4-6h 1 76.2 
4-6h_Ind-pos_2 IC-dsRed dsRed 
Intermediate 
column 
Enriched 4-6h 2 81.6 
4-6h_Vnd-neg_1 VC-dsRed dsRed Ventral column Depleted 4-6h 1 62.6 
4-6h_Vnd-neg_2 VC-dsRed dsRed Ventral column Depleted 4-6h 2 64.3 
4-6h_Vnd-pos_1 VC-dsRed dsRed Ventral column Enriched 4-6h 1 61.4 
















Prospero Neuroblasts Enriched 4-6h 2 59.1 
6-8h_Ind-neg_1 IC-GFP GFP 
Intermediate 
column 
Depleted 6-8h 1 61 
6-8h_Ind-neg_2 IC-GFP GFP 
Intermediate 
column 
Depleted 6-8h 2 59.9 
6-8h_Ind-pos_1 IC-GFP GFP 
Intermediate 
column 
Enriched 6-8h 1 57 
6-8h_Ind-pos_2 IC-GFP GFP 
Intermediate 
column 
Enriched 6-8h 2 70.9 
6-8h_Vnd-neg_1 VC-dsRed dsRed Ventral column Depleted 6-8h 1 73.2 
6-8h_Vnd-neg_2 VC-dsRed dsRed Ventral column Depleted 6-8h 2 61 
6-8h_Vnd-pos_1 VC-dsRed dsRed Ventral column Enriched 6-8h 1 61.6 
















Prospero Neuroblasts Enriched 6-8h 2 58.8 
6-8h_Elav-neg_1 IC-GFP Elav Neurons Depleted 6-8h 1 62.2 
6-8h_Elav-neg_2 yw Elav Neurons Depleted 6-8h 2 57.2 
6-8h_Elav-pos_1 IC-GFP Elav Neurons Enriched 6-8h 1 53.8 
6-8h_Elav-pos_2 yw Elav Neurons Enriched 6-8h 2 70.4 
6-8h_Repo-neg_1 IC-GFP Repo Glia Depleted 6-8h 1 59.6 
6-8h_Repo-neg_2 IC-GFP Repo Glia Depleted 6-8h 2 71.4 
6-
8h_Repo_pos_1 
IC-GFP Repo Glia Enriched 6-8h 1 66.6 
6-
8h_Repo_pos_2 
IC-GFP Repo Glia Enriched 6-8h 2 56.8 
8-10h_Elav-neg_1 y w Elav Neurons Depleted 8-10h 1 74.5 
8-10h_Elav-neg_2 y w Elav Neurons Depleted 8-10h 2 44.1 
8-10h_Elav-pos_1 y w Elav Neurons Enriched 8-10h 1 69.9 















Repo Glia Enriched 8-10h 1 61.4 





















Table S11: Summary of RNA-seq datasets – Fractionation-Seq 
Sample name Fly line Fraction Time 
point 




18-22h 1 163.2 
Cyto_18-22h_2 rho-lexA/VC:FNLDD Cytoplasmi
c 
18-22h 2 179.1 
Cyto_6-8h_1 rho-lexA/VC:FNLDD Cytoplasmi
c 
6-8h 1 189.3 
Cyto_6-8h_2 rho-lexA/VC:FNLDD Cytoplasmi
c 
6-8h 2 179.3 
Nuc_18-22h_1 rho-lexA/VC:FNLDD Nuclear 18-22h 1 203 
Nuc_18-22h_2 rho-lexA/VC:FNLDD Nuclear 18-22h 2 176.1 
Nuc_6-8h_1 rho-lexA/VC:FNLDD Nuclear 6-8h 1 193.9 
Nuc_6-8h_2 rho-lexA/VC:FNLDD Nuclear 6-8h 2 193.7 
Whole_18-22h_1 rho-lexA/VC:FNLDD Whole 
embryo 
18-22h 1 183.2 
Whole_18-22h_2 rho-lexA/VC:FNLDD Whole 
embryo 
18-22h 2 180.7 
Whole_6-8h_1 rho-lexA/VC:FNLDD Whole 
embryo 
6-8h 1 197.4 
Whole_6-8h_2 rho-lexA/VC:FNLDD Whole 
embryo 













































Repo Glia Enriched 18-22h 2 75.9 





















Table S12: All protein-coding ‘computed genes’ correlated (r > 0.9) with neurogenic marker genes in 
DIV-SortSeq expression data












































































































































































































































Fig. S1: Neurogenic cell populations can be faithfully marked and purified 
(A) Visualization of fluorescent reporter expression in VC-dsRed (top panel) and IC-dsRed (bottom panel) 
transgenic embryos. Tissue reporter shown on left and in red by antibody stain, expression of the tissue 
marker is shown in the middle and in green by in situ hybridization. Shown are whole mount embryos, 
ventral views anterior left. (B) Multiplex whole mount immunohistochemistry (green) and RNA-FISH 
(magenta) show faithfulness of the antibody sorting markers for neuroblasts (Pros; top panel) at 4-6h, and 
neurons (Elav; middle panel) and glia (Repo; bottom panel) at 8-10h. (C) Immunohistochemical staining 
of endogenous Elav protein in cells of dissociated embryos pre- and post-FACS.  






















Fig. S2: Timed embryo collections encompass major neurogenic events 
(A) Overview of Drosophila embryonic neurogenesis, timing and stages. Embryo images show stages of 
neurogenesis schematically and were obtained from the Atlas of Drosophila Development by Volker 
Hartstein (CSHL Press, 1992, used with permission). (B) Staging of representative samples 
corresponding to timed embryo collections (n = 2-3 collections per line). Staging according to (Campos-
Ortega & Hartenstein 1985). Cell type markers targeted for DIV-MARIS indicated for each fly line. 
  






















Fig. S3: FACS gating strategy yields high purity of sorted populations 
(A) Example FACS gating strategy for sorting of marker-positive (P5; 6.7%) and marker-negative cells 
(P4; 79%). (B) Re-sort of marker-positive sorted cells shows enrichment of marker-positive (P5; 90.4%) 
and depletion of marker-negative cells (P4; 5.9%). 
  


































































Fig. S4:  Principal component analyses separate spatiotemporal transcriptomes according to 
tissue and developmental age 
Principal Component Analysis (PCA) with multiple permutations of datasets generated by DIV-SortSeq. 
Marker-enriched datasets depicted in red, marker-depleted datasets in black. (A) All datasets. (B). Only 
marker-positive datasets. (C). Only early (4-6, 6-8, 8-10h) datasets. (D) Only 6-8h datasets. (E). Only 18-
22h datasets. (F). Only datasets sorted for ind expression. (G). All datasets sorted for vnd expression. (H) 
All datasets sorted for pros expression. (I) All datasets sorted for elav expression. (J) All datasets sorted 
on repo expression.   











































 Fig. S5: Cell type specific transcriptomes at neurogenic marker genes 
(A-E) Genome browser data of cell type specific transcriptomes around marker gene loci. Shown are 
annotated transcripts (top), RNA-seq coverage on the plus- (red) or minus-strand (blue) in the indicated 
sorts at 6-8hrs AEL, as well as coding potential as measured by PhyloCSF scores (all frames overlaid), 
and conservation amongst Drosophilids (phastCons). (A) ind locus. (B) vnd locus. (C) pros locus. (D) elav 
locus. (E) repo locus. 
  






















Fig. S6: Annotations of regulated protein-coding genes predict expression and function 
Analysis of features of 794 protein-coding genes correlated with known neurogenic genes (Pearson 
correlation, r > 0.9) with Flymine {Lyne:2007jd}. (A) Top ImaGO terms. (B) Top GO terms (molecular 
function). (C) Top GO terms (biological process). (D) Top protein domain terms. Detailed analysis of all 
genes can be found in File S2. 
  











































Fig. S7: DIV-SortSeq reveals a multitude of undescribed genes expressed with neurogenic 
spatiotemporal specificity 
(A) Heatmap of expression profiles of protein-coding genes with unknown function enriched similarly as at 
least one marker in Fig. 2B (Pearson correlation, r > 0.9). Row mean-centered expression values 
calculated via variance-stabilizing transformation of gene-level RNA-seq counts (scale = log2 ratio to row 
mean). (B) Colorimetric RNA in situ hybridization of transcripts of unknown function identified in Fig. S7A. 
All embryos are shown in lateral orientation. Images obtained from Berkeley Drosophila Genome Project 
(Hammonds et al. 2013; Tomancak et al. 2002; Tomancak et al. 2007). A list of all 212 CGs with r>0.9 is 
available in Table S12.













































Figure S8: Cell type specific transcriptomes at neurogenic lncRNA loci 
Browser images of selected lncRNA loci, display as in Figure S4: The (A) CR44272, (B) CR46003 and 
CR46004 (pri-miR-276b), (C) CR32730, (D) cherub, (E) CR44024, (F) CR32111, (G) CR44596, (H) 
CR44922, (I) CR45312, (J) CR44978, (K) CR45332 (This gene model might be misannotated – CR45332 and 
CR45333 might be a single transcript), and the (L) CR44596 and CR44597 locus.   























Fig. S9: The lncRNA CR30009 is expressed in glial subsets in early embryos 
RNA fluorescent in situ hybridization (RNA-FISH) against CR30009 and the glial marker repo. 
(A) Lateral view, stage 9/10. (B) Ventral view, stage 9/10. Top: CR30009 alone. Second from top: 
CR30009 (magenta) overlaid with repo (green). Dashed white box indicates region of interest (ROI) and 
yellow line indicates Z-slice through ROI. Second from bottom: zoom-in of ROI. Bottom: Slice through Z-
stack as indicated by yellow line. 
  






















Fig. S10: The lncRNA CR30009 is expressed in neuroblast subsets 
RNA fluorescent in situ hybridization (RNA-FISH) against CR30009 and the neuroblast marker pros. (A) 
Lateral view, stage 11/12. (B) Lateral view, stage 14/15. (C) Ventral view; stage 11/12. (D). Ventral view; 
stage 14/15. Top: CR30009 alone. Second from top: CR30009 (magenta) overlaid with pros (green). 
Dashed white box indicates region of interest (ROI) and yellow line indicates Z-slice through ROI. Second 
from bottom: zom-in of ROI. Bottom: Slice through Z-stack as indicated by yellow line.   






















Fig S11: The lncRNA cherub is regulated with strict spatiotemporal specificity. 
RNA fluorescent in situ hybridization (RNA-FISH) against cherub, the neuroblast marker pros, and the 
neuronal marker elav. Lateral view. (A) cherub with pros; stage 13. (B) cherub with elav; stage 13. (C) 
cherub with pros; stage 15. (D) cherub with elav; stage 14. Top: cherub alone. Second from top: cherub 
(magenta) overlaid with marker (green). 
  






















Fig S12: The lncRNA cherub is expressed in glial subsets in late embryos 
RNA fluorescent in situ hybridization (RNA-FISH) against cherub and the glial marker repo. (A) Ventral 
view; stage 15. (B) Lateral view; stage 16/17. Top: cherub alone. Second from top: cherub (magenta) 
overlaid with repo (green). Dashed white box indicates region of interest (ROI) and yellow line indicates Z-
slice through ROI. Second from bottom: zom-in of ROI. Bottom: Slice through Z-stack as indicated by 
yellow line. 
  






















Fig S13: The lncRNA CR46003 is expressed in early embryogenesis 
RNA fluorescent in situ hybridization (RNA-FISH) against CR46003 with the neuroblast marker pros. (A) 
Dorsal view; stage 5/6. (B) Lateral view; stage 7/8. Top: DAPI, middle: CR46003 alone. Bottom: CR46003 
(magenta) overlaid with pros (green). 
  






















Fig S14: The lncRNAs CR46003 and CR32730 are expressed with similar spatiotemporal 
specificity. 
RNA fluorescent in situ hybridization (RNA-FISH) against CR46003 and CR32730 together with the 
neuroblast marker pros. Lateral view. (A) CR46003; stage 10. (B) CR46003; stage 11/12. (C) CR46003; 
stage 14. (D) CR32730; stage 9. (E) CR32730; stage 12. (F) CR32730; stage 13. Top: lncRNA alone. 
Second from top: lncRNA (magenta) overlaid with pros (green).   






















Fig S15: The lncRNA CR46003 is expressed in neuronal subsets 
RNA fluorescent in situ hybridization (RNA-FISH) against CR46003 with the neuronal marker, elav. 
Ventral view. (A) Stage 10/11. (B) Stage 12/13. Top: CR46003 alone. Second from top: CR46003 
(magenta) overlaid with elav (green). Dashed white box indicates region of interest (ROI) and yellow line 
indicates Z-slice through ROI. Second from bottom: zom-in of ROI. Bottom: Slice through Z-stack as 
indicated by yellow line. 
  






















Fig S16: The lncRNA CR44024 is expressed from stage 12 in neuronal subsets of the ventral nerve 
cord. 
RNA fluorescent in situ hybridization (RNA-FISH) against CR44024 with the neuronal marker, elav. 
Ventral view, stage 12. Top: CR44024 alone. Second from top: CR44024 (magenta) overlaid with elav 
(green). Dashed white box indicates region of interest (ROI) and yellow line indicates Z-slice through ROI. 
Second from bottom: zom-in of ROI. Bottom: Slice through Z-stack as indicated by yellow line. 
  






















Fig S17: LncRNAs exhibit varying patterns of subcellular distribution 
RNA fluorescent in situ hybridization (RNA-FISH) against lncRNAs (green) overlaid with the nucleic acid 
marker, DAPI (magenta). (A) CR30009; central brain, stage 12. (B) cherub; ventral nerve cord, stage 14. 
(C) CR46003; central brain, stage 10. (D) CR32730; central brain, stage 12. (E) CR44024; ventral nerve 
cord, stage 14. (A) Left panel: Dashed white box indicates region of interest (ROI). Right panel: zom-in of 
ROI. (B-E) Top panel: Dashed white box indicates region of interest (ROI). Bottom panel: zoom-in of ROI.   
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